'Twelve new 2- 2"-carbomyl - 5" - [3'-amino-2' – methylmono / dihalosubstituted quinazolin- 4' (3'H) - onomethylene] – 1",3",4" - oxadiazol-2"-yl} -4, 5- dihydroimidazolines were prepared and evaluated for their cardiovascular activity. The most active compound of this series is 2-2"-carbomyl-5"-[3'-amino-2'-methyl-6-bromoquinazolin-4'(3'H)-onomethylene]-",3",4"-oxadiazol-2"-yl}-4,5-dihydroimidazolines i.e. compound VIc.
制备并评价了12种新的2-2"-羧基-5"-[3'-
氨基-2'-甲基单/二卤代喹唉-4'(3'H)-亚甲基]-",3",4"-噁二唑-2"-基}-4,5-二氢
咪唑啉的心血管活性。其中最活性的化合物为2-2"-羧基-5"-[3'-
氨基-2'-甲基-
6-溴喹唑啉-4'(3'H)-亚甲基]-",3",4"-噁二唑-2"-基}-4,5-二氢
咪唑啉,即化合物VIc。